 Connection
Robert Ryu to Treatment Outcome
This is a "connection" page, showing publications Robert Ryu has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.972 |
|
|
|
-
Trivedi PS, Jensen AM, Kriss MS, Brown MA, Morgan RL, Lindrooth RC, Ho PM, Ryu RK. Ethnoracial Disparity in Hospital Survival following Transjugular Intrahepatic Portosystemic Shunt Creation for Acute Variceal Bleeding in the United States. J Vasc Interv Radiol. 2021 07; 32(7):941-949.e3.
Score: 0.066
-
Trivedi PS, Lind KE, Ray CE, Rochon PJ, Ryu RK. Race and Sex Disparities in Outcomes of Dialysis Access Maintenance Interventions. J Vasc Interv Radiol. 2018 04; 29(4):476-481.e1.
Score: 0.052
-
Trivedi PS, Rochon PJ, Durham JD, Ryu RK. National Trends and Outcomes of Transjugular Intrahepatic Portosystemic Shunt Creation Using the Nationwide Inpatient Sample. J Vasc Interv Radiol. 2016 Jun; 27(6):838-45.
Score: 0.046
-
Gipson MG, Smith MT, Durham JD, Brown A, Johnson T, Ray CE, Gupta RK, Kondo KL, Rochon PJ, Ryu RK. Intravascular US-Guided Portal Vein Access: Improved Procedural Metrics during TIPS Creation. J Vasc Interv Radiol. 2016 Aug; 27(8):1140-7.
Score: 0.046
-
Sutter CM, Ryu RK. Percutaneous Management of Malignant Biliary Obstruction. Tech Vasc Interv Radiol. 2015 Dec; 18(4):218-26.
Score: 0.044
-
Ryu RK, Desai K, Karp J, Gupta R, Evans AE, Rajeswaran S, Salem R, Lewandowski RJ. A Comparison of Retrievability: Celect versus Option Filter. J Vasc Interv Radiol. 2015 Jun; 26(6):865-9.
Score: 0.043
-
Andreoli JM, Lewandowski RJ, Vogelzang RL, Ryu RK. Comparison of complication rates associated with permanent and retrievable inferior vena cava filters: a review of the MAUDE database. J Vasc Interv Radiol. 2014 Aug; 25(8):1181-5.
Score: 0.041
-
Eifler AC, Lewandowski RJ, Gupta R, Karp J, Salem R, Lee J, Ryu RK. Optional or permanent: clinical factors that optimize inferior vena cava filter utilization. J Vasc Interv Radiol. 2013 Jan; 24(1):35-40.
Score: 0.037
-
Chung JC, Wang D, Lewandowski RJ, Tang R, Chrisman HB, Vogelzang RL, Woloschak GE, Larson AC, Omary RA, Ryu RK. Four-dimensional transcatheter intra-arterial perfusion MR imaging before and after uterine artery embolization in the rabbit VX2 tumor model. J Magn Reson Imaging. 2010 May; 31(5):1137-43.
Score: 0.031
-
Timperman PE, Sichlau M, Ryu RK. Greater energy delivery improves treatment success of endovenous laser treatment of incompetent saphenous veins. J Vasc Interv Radiol. 2004 Oct; 15(10):1061-3.
Score: 0.021
-
Huang C, He X, Xie Y, Chen H, Ye Y, Sun Y, Dharmakumar R, Ryu RK, Li D, Xie G, Fan Z. Thrombus Signal on T1-Weighted Black-Blood MR Predicts Outcomes of Catheter-Directed Thrombolysis in Acute Deep Vein Thrombosis. Thromb Haemost. 2023 Apr; 123(4):453-463.
Score: 0.019
-
Rao SS, Jensen AM, Kriss MS, Morgan RL, Ho PM, Ryu RK, Trivedi PS. Racial Differences in the Use of Endoscopy and Transjugular Intrahepatic Portosystemic Shunt Creation for Treatment of Acute Variceal Bleeding in the United States. J Vasc Interv Radiol. 2022 04; 33(4):465-468.e1.
Score: 0.017
-
Trivedi PS, Jensen AM, Brown MA, Morgan RL, Lindrooth RC, Ryu RK, Ho PM, Kriss MS. High Prevalence of Transjugular Intrahepatic Portosystemic Shunt Creation Without Prior Endoscopy During Acute Variceal Bleeding Hospitalization in the United States. Hepatol Commun. 2021 10; 5(10):1784-1790.
Score: 0.017
-
Kirkpatrick DL, Lindquist J, Jensen AM, Reghunathan A, Brown MA, Schramm KM, Ryu RK, Trivedi PS. Comparative efficacy and safety of the Captus device for inferior vena cava filter retrieval. Clin Imaging. 2021 Sep; 77:202-206.
Score: 0.016
-
Trivedi PS, Brown MA, Rochon PJ, Ryu RK, Johnson DT. Gender Disparity in Inpatient Mortality After Transjugular Intrahepatic Portosystemic Shunt Creation in Patients Admitted With Hepatorenal Syndrome: A Nationwide Study. J Am Coll Radiol. 2020 Feb; 17(2):231-237.
Score: 0.015
-
Hammad H, Brauer BC, Smolkin M, Ryu R, Obuch J, Shah RJ. Treating Biliary-Enteric Anastomotic Strictures with Enteroscopy-ERCP Requires Fewer Procedures than Percutaneous Transhepatic Biliary Drains. Dig Dis Sci. 2019 09; 64(9):2638-2644.
Score: 0.014
-
Wadhwa V, Gutta NB, Trivedi PS, Chatterjee K, Ahmed O, Ryu RK, Kalva SP. In-Hospital Mortality Benefit of Inferior Vena Cava Filters in Patients With Pulmonary Embolism and Congestive Heart Failure. AJR Am J Roentgenol. 2018 09; 211(3):672-676.
Score: 0.014
-
Holly BP, Gaba RC, Lessne ML, Lewandowski RJ, Ryu RK, Desai KR, Sing RF. Vena Cava Filter Retrieval with Aorto-Iliac Arterial Strut Penetration. Cardiovasc Intervent Radiol. 2018 Aug; 41(8):1184-1188.
Score: 0.013
-
Desai KR, Laws JL, Salem R, Mouli SK, Errea MF, Karp JK, Yang Y, Ryu RK, Lewandowski RJ. Defining Prolonged Dwell Time: When Are Advanced Inferior Vena Cava Filter Retrieval Techniques Necessary? An Analysis in 762 Procedures. Circ Cardiovasc Interv. 2017 Jun; 10(6).
Score: 0.013
-
Yoon DY, Vavra AK, Eifler AC, Teter K, Eskandari MK, Ryu RK, Rodriguez HE. Why Temporary Filters Are Not Removed: Clinical Predictors in 1,000 Consecutive Cases. Ann Vasc Surg. 2017 Jul; 42:64-70.
Score: 0.012
-
Salem R, Vouche M, Baker T, Herrero JI, Caicedo JC, Fryer J, Hickey R, Habib A, Abecassis M, Koller F, Vogelzang R, Desai K, Thornburg B, Hohlastos E, Resnick S, Lewandowski RJ, Sato K, Ryu RK, Ganger D, Kulik L. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis. Transplantation. 2015 Nov; 99(11):2347-55.
Score: 0.011
-
Wang D, Gaba RC, Jin B, Lewandowski RJ, Riaz A, Memon K, Ryu RK, Sato KT, Kulik LM, Mulcahy MF, Larson AC, Salem R, Omary RA. Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma. Radiology. 2014 Aug; 272(2):587-97.
Score: 0.010
-
Memon K, Kulik LM, Lewandowski RJ, Wang E, Wang J, Ryu RK, Hickey R, Vouche M, Baker T, Ganger D, Gates VL, Habib A, Mulcahy MF, Salem R. Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization. J Vasc Interv Radiol. 2014 Jul; 25(7):1056-66.
Score: 0.010
-
Hamoui N, Minocha J, Memon K, Sato K, Ryu R, Salem R, Lewandowski RJ. Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres. J Vasc Interv Radiol. 2013 Nov; 24(11):1743-5.
Score: 0.010
-
Mouli SK, Tyler P, McDevitt JL, Eifler AC, Guo Y, Nicolai J, Lewandowski RJ, Li W, Procissi D, Ryu RK, Wang YA, Salem R, Larson AC, Omary RA. Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors. ACS Nano. 2013 Sep 24; 7(9):7724-33.
Score: 0.010
-
Hickey R, Vouche M, Sze DY, Hohlastos E, Collins J, Schirmang T, Memon K, Ryu RK, Sato K, Chen R, Gupta R, Resnick S, Carr J, Chrisman HB, Nemcek AA, Vogelzang RL, Lewandowski RJ, Salem R. Cancer concepts and principles: primer for the interventional oncologist-part II. J Vasc Interv Radiol. 2013 Aug; 24(8):1167-88.
Score: 0.010
-
Hickey R, Vouche M, Sze DY, Hohlastos E, Collins J, Schirmang T, Memon K, Ryu RK, Sato K, Chen R, Gupta R, Resnick S, Carr J, Chrisman HB, Nemcek AA, Vogelzang RL, Lewandowski RJ, Salem R. Cancer concepts and principles: primer for the interventional oncologist-part I. J Vasc Interv Radiol. 2013 Aug; 24(8):1157-64.
Score: 0.010
-
Vouche M, Lewandowski RJ, Atassi R, Memon K, Gates VL, Ryu RK, Gaba RC, Mulcahy MF, Baker T, Sato K, Hickey R, Ganger D, Riaz A, Fryer J, Caicedo JC, Abecassis M, Kulik L, Salem R. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol. 2013 Nov; 59(5):1029-36.
Score: 0.010
-
Mouli S, Memon K, Baker T, Benson AB, Mulcahy MF, Gupta R, Ryu RK, Salem R, Lewandowski RJ. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol. 2013 Aug; 24(8):1227-34.
Score: 0.009
-
Memon K, Kulik L, Lewandowski RJ, Gupta R, Ryu RK, Miller FH, Vouche M, Atassi R, Ganger D, Mulcahy MF, Salem R. Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials. J Vasc Interv Radiol. 2013 Aug; 24(8):1189-1197.e2.
Score: 0.009
-
Esparaz AM, Ryu RK, Gupta R, Resnick SA, Salem R, Lewandowski RJ. Fibrin cap disruption: an adjunctive technique for inferior vena cava filter retrieval. J Vasc Interv Radiol. 2012 Sep; 23(9):1233-5.
Score: 0.009
-
Guo Y, Zhang Y, Jin N, Klein R, Nicolai J, Lewandowski RJ, Ryu RK, Omary RA, Larson AC. Electroporation-mediated transcatheter arterial chemoembolization in the rabbit VX2 liver tumor model. Invest Radiol. 2012 Feb; 47(2):116-20.
Score: 0.009
-
Memon K, Kulik L, Lewandowski RJ, Wang E, Ryu RK, Riaz A, Nikolaidis P, Miller FH, Yaghmai V, Baker T, Abecassis M, Benson AB, Mulcahy MF, Omary RA, Salem R. Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis. J Hepatol. 2012 May; 56(5):1112-1120.
Score: 0.009
-
Memon K, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Gates VL, Atassi B, Newman S, Omary RA, Benson AB, Salem R. Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):887-94.
Score: 0.009
-
Ibrahim SM, Kulik L, Baker T, Ryu RK, Mulcahy MF, Abecassis M, Salem R, Lewandowski RJ. Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization. Cardiovasc Intervent Radiol. 2012 Oct; 35(5):1094-101.
Score: 0.009
-
Jin B, Wang D, Lewandowski RJ, Ryu RK, Sato KT, Larson AC, Salem R, Omary RA. Quantitative 4D transcatheter intraarterial perfusion MRI for standardizing angiographic chemoembolization endpoints. AJR Am J Roentgenol. 2011 Nov; 197(5):1237-43.
Score: 0.009
-
Sato KT, Wang D, Lewandowski RJ, Ryu RK, Klein RA, Salem R, Larson AC, Omary RA. Four-dimensional transcatheter intraarterial perfusion MRI monitoring of radiofrequency ablation of rabbit VX2 liver tumors. J Magn Reson Imaging. 2011 Sep; 34(3):563-9.
Score: 0.008
-
Wang D, Gaba RC, Jin B, Riaz A, Lewandowski RJ, Ryu RK, Sato KT, Ragin AB, Kulik LM, Mulcahy MF, Salem R, Larson AC, Omary RA. Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma. Acad Radiol. 2011 Jul; 18(7):828-36.
Score: 0.008
-
Memon K, Kulik L, Lewandowski RJ, Wang E, Riaz A, Ryu RK, Sato KT, Marshall K, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Senthilnathan S, Baker T, Gates VL, Abecassis M, Benson AB, Mulcahy MF, Omary RA, Salem R. Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. Gastroenterology. 2011 Aug; 141(2):526-35, 535.e1-2.
Score: 0.008
-
Salem R, Lewandowski RJ, Gates VL, Nutting CW, Murthy R, Rose SC, Soulen MC, Geschwind JF, Kulik L, Kim YH, Spreafico C, Maccauro M, Bester L, Brown DB, Ryu RK, Sze DY, Rilling WS, Sato KT, Sangro B, Bilbao JI, Jakobs TF, Ezziddin S, Kulkarni S, Kulkarni A, Liu DM, Valenti D, Hilgard P, Antoch G, Muller SP, Alsuhaibani H, Mulcahy MF, Burrel M, Real MI, Spies S, Esmail AA, Raoul JL, Garin E, Johnson MS, Benson AB, Sharma RA, Wasan H, Lambert B, Memon K, Kennedy AS, Riaz A. Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol. 2011 Mar; 22(3):265-78.
Score: 0.008
-
Salem R, Lewandowski RJ, Kulik L, Wang E, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Ibrahim SM, Senthilnathan S, Baker T, Gates VL, Atassi B, Newman S, Memon K, Chen R, Vogelzang RL, Nemcek AA, Resnick SA, Chrisman HB, Carr J, Omary RA, Abecassis M, Benson AB, Mulcahy MF. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2011 Feb; 140(2):497-507.e2.
Score: 0.008
-
Chung JC, Naik NK, Lewandowski RJ, Deng J, Mulcahy MF, Kulik LM, Sato KT, Ryu RK, Salem R, Larson AC, Omary RA. Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization. World J Gastroenterol. 2010 Jul 07; 16(25):3161-7.
Score: 0.008
-
Gaba RC, Riaz A, Lewandowski RJ, Ibrahim SM, Ryu RK, Sato KT, Omary RA, Salem R. Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction. J Vasc Interv Radiol. 2010 Aug; 21(8):1213-8.
Score: 0.008
-
Lewandowski RJ, Mulcahy MF, Kulik LM, Riaz A, Ryu RK, Baker TB, Ibrahim SM, Abecassis MI, Miller FH, Sato KT, Senthilnathan S, Resnick SA, Wang E, Gupta R, Chen R, Newman SB, Chrisman HB, Nemcek AA, Vogelzang RL, Omary RA, Benson AB, Salem R. Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology. 2010 Jun; 255(3):955-65.
Score: 0.008
-
Wang D, Jin B, Lewandowski RJ, Ryu RK, Sato KT, Mulcahy MF, Kulik LM, Miller FH, Salem R, Li D, Omary RA, Larson AC. Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma. J Magn Reson Imaging. 2010 May; 31(5):1106-16.
Score: 0.008
-
Riaz A, Miller FH, Kulik LM, Nikolaidis P, Yaghmai V, Lewandowski RJ, Mulcahy MF, Ryu RK, Sato KT, Gupta R, Wang E, Baker T, Abecassis M, Benson AB, Nemcek AA, Omary R, Salem R. Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma. JAMA. 2010 Mar 17; 303(11):1062-9.
Score: 0.008
-
Duke E, Deng J, Ibrahim SM, Lewandowski RJ, Ryu RK, Sato KT, Miller FH, Kulik L, Mulcahy MF, Larson AC, Salem R, Omary RA. Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization. J Vasc Interv Radiol. 2010 Apr; 21(4):515-21.
Score: 0.008
-
Yu M, Lewandowski RJ, Ibrahim S, Riaz A, Ryu RK, Benito A, Alonso-Burgos A, Bilbao JI, Salem R. Direct hepatic artery puncture for transarterial therapy in liver cancer. J Vasc Interv Radiol. 2010 Mar; 21(3):394-9.
Score: 0.008
-
Riaz A, Lewandowski RJ, Kulik L, Ryu RK, Mulcahy MF, Baker T, Gates V, Nayar R, Wang E, Miller FH, Sato KT, Omary RA, Abecassis M, Salem R. Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization. Cardiovasc Intervent Radiol. 2010 Dec; 33(6):1143-52.
Score: 0.007
-
Dunfee BL, Riaz A, Lewandowski RJ, Ibrahim S, Mulcahy MF, Ryu RK, Atassi B, Sato KT, Newman S, Omary RA, Benson A, Salem R. Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survival. J Vasc Interv Radiol. 2010 Jan; 21(1):90-5.
Score: 0.007
-
Lewandowski RJ, Riaz A, Ryu RK, Mulcahy MF, Sato KT, Kulik LM, Gates VL, Baker T, Omary R, Salem R. Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study. J Vasc Interv Radiol. 2009 Dec; 20(12):1557-63.
Score: 0.007
-
Sato KT, Omary RA, Takehana C, Ibrahim S, Lewandowski RJ, Ryu RK, Salem R. The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases. J Vasc Interv Radiol. 2009 Dec; 20(12):1564-9.
Score: 0.007
-
Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, Atassi B, Baker T, Gates V, Miller FH, Sato KT, Wang E, Gupta R, Benson AB, Newman SB, Omary RA, Abecassis M, Kulik L. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology. 2010 Jan; 138(1):52-64.
Score: 0.007
-
Lewandowski RJ, Kulik LM, Riaz A, Senthilnathan S, Mulcahy MF, Ryu RK, Ibrahim SM, Sato KT, Baker T, Miller FH, Omary R, Abecassis M, Salem R. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant. 2009 Aug; 9(8):1920-8.
Score: 0.007
-
Gaba RC, Wang D, Lewandowski RJ, Ryu RK, Sato KT, Kulik LM, Mulcahy MF, Larson AC, Salem R, Omary RA. Four-dimensional transcatheter intraarterial perfusion MR imaging for monitoring chemoembolization of hepatocellular carcinoma: preliminary results. J Vasc Interv Radiol. 2008 Nov; 19(11):1589-95.
Score: 0.007
-
Rhee TK, Naik NK, Deng J, Atassi B, Mulcahy MF, Kulik LM, Ryu RK, Miller FH, Larson AC, Salem R, Omary RA. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging. J Vasc Interv Radiol. 2008 Aug; 19(8):1180-6.
Score: 0.007
-
Ibrahim SM, Lewandowski RJ, Ryu RK, Sato KT, Gates VL, Mulcahy MF, Kulik L, Larson AC, Omary RA, Salem R. Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments. Cardiovasc Intervent Radiol. 2008 Nov-Dec; 31(6):1124-32.
Score: 0.007
-
Ibrahim SM, Lewandowski RJ, Sato KT, Gates VL, Kulik L, Mulcahy MF, Ryu RK, Omary RA, Salem R. Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review. World J Gastroenterol. 2008 Mar 21; 14(11):1664-9.
Score: 0.007
-
Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, Nemcek AA, Barakat O, Benson A, Mandal R, Talamonti M, Wong CY, Miller FH, Newman SB, Shaw JM, Thurston KG, Omary RA, Salem R. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. Radiology. 2008 May; 247(2):507-15.
Score: 0.007
-
Atassi B, Bangash AK, Lewandowski RJ, Ibrahim S, Kulik L, Mulcahy MF, Murthy R, Ryu RK, Sato KT, Miller FH, Omary RA, Salem R. Biliary sequelae following radioembolization with Yttrium-90 microspheres. J Vasc Interv Radiol. 2008 May; 19(5):691-7.
Score: 0.007
-
Lewandowski RJ, Tepper J, Wang D, Ibrahim S, Miller FH, Kulik L, Mulcahy M, Ryu RK, Sato K, Larson AC, Salem R, Omary RA. MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization. J Vasc Interv Radiol. 2008 May; 19(5):698-705.
Score: 0.007
-
Larson AC, Wang D, Atassi B, Sato KT, Ryu RK, Lewandowski RJ, Nemcek AA, Mulcahy MF, Kulik LM, Miller FH, Salem R, Omary RA. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation. Radiology. 2008 Mar; 246(3):964-71.
Score: 0.007
-
Jakobs TF, Saleem S, Atassi B, Reda E, Lewandowski RJ, Yaghmai V, Miller F, Ryu RK, Ibrahim S, Sato KT, Kulik LM, Mulcahy MF, Omary R, Murthy R, Reiser MF, Salem R. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres. Dig Dis Sci. 2008 Sep; 53(9):2556-63.
Score: 0.007
-
Kulik LM, Carr BI, Mulcahy MF, Lewandowski RJ, Atassi B, Ryu RK, Sato KT, Benson A, Nemcek AA, Gates VL, Abecassis M, Omary RA, Salem R. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology. 2008 Jan; 47(1):71-81.
Score: 0.007
-
Atassi B, Bangash AK, Bahrani A, Pizzi G, Lewandowski RJ, Ryu RK, Sato KT, Gates VL, Mulcahy MF, Kulik L, Miller F, Yaghmai V, Murthy R, Larson A, Omary RA, Salem R. Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. Radiographics. 2008 Jan-Feb; 28(1):81-99.
Score: 0.007
-
Lewandowski RJ, Wang D, Gehl J, Atassi B, Ryu RK, Sato K, Nemcek AA, Miller FH, Mulcahy MF, Kulik L, Larson AC, Salem R, Omary RA. A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring. J Vasc Interv Radiol. 2007 Oct; 18(10):1249-57.
Score: 0.006
-
Bangash AK, Atassi B, Kaklamani V, Rhee TK, Yu M, Lewandowski RJ, Sato KT, Ryu RK, Gates VL, Newman S, Mandal R, Gradishar W, Omary RA, Salem R. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. J Vasc Interv Radiol. 2007 May; 18(5):621-8.
Score: 0.006
-
Rhee TK, Ryu RK, Bangash AK, Wang D, Szolc-Kowalska B, Harris KR, Sato KT, Chrisman HB, Vogelzang RL, Paunesku T, Woloschak GE, Larson AC, Omary RA. Rabbit VX2 tumors as an animal model of uterine fibroids and for uterine artery embolization. J Vasc Interv Radiol. 2007 Mar; 18(3):411-8.
Score: 0.006
-
Chrisman HB, Minocha J, Ryu RK, Vogelzang RL, Nikolaidis P, Omary RA. Uterine artery embolization: a treatment option for symptomatic fibroids in postmenopausal women. J Vasc Interv Radiol. 2007 Mar; 18(3):451-4.
Score: 0.006
-
Coldwell DM, Novak Z, Ryu RK, Brega KE, Biffl WL, Offner PJ, Franciose RJ, Burch JM, Moore EE. Treatment of posttraumatic internal carotid arterial pseudoaneurysms with endovascular stents. J Trauma. 2000 Mar; 48(3):470-2.
Score: 0.004
-
Biffl WL, Moore EE, Ryu RK, Offner PJ, Novak Z, Coldwell DM, Franciose RJ, Burch JM. The unrecognized epidemic of blunt carotid arterial injuries: early diagnosis improves neurologic outcome. Ann Surg. 1998 Oct; 228(4):462-70.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|